Financials
- Market Capitalization 2.46 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1819 | VRDN Viridian Therapeutics, Inc. - Common Stock | 22.90 USD | -0.78% | -4.78% | +21.81% | +2.00% | 2.59 B USD | ||
| 1854 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.08 USD | -2.07% | -2.94% | +0.64% | -17.77% | 2.47 B USD | ||
| 1861 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.58 USD | -2.44% | -1.03% | +6.44% | +14.46% | 2.45 B USD | ||
| 1866 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 33.65 USD | -1.58% | -1.23% | +5.75% | +13.15% | 2.42 B USD |